{"SPADE_N_15183": {"Sequence Information": {"Peptide Name": "Daptomycin, Cubicin, Cidecin", "Sequence": "WNDTGXDADGSXX", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Streptomyces roseosporus\n2. Streptomyces filamentosus", "Gene": "", "PDB ID": "1XT7", "UniProt Entry": [], "Literature": [{"Title": "Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens", "Pubmed ID": "29434326", "Reference": "Nat Microbiol. 2018;3:415-422", "Author": "Hover BM, Kim SH, Katz M, Charlop-Powers Z, Owen J, Ternei MA, Maniko J, Estrela AB, Molina H, Park S, Perlin DS, Brady SF", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29434326"}, {"Title": "Targeted Antibiotic Delivery: Selective Siderophore Conjugation with Daptomycin Confers Potent Activity against Multidrug Resistant Acinetobacter baumannii Both in Vitro and in Vivo.", "Pubmed ID": "28287735", "Reference": "J Med Chem. 2017;60:4577-4583", "Author": "Ghosh M, Miller PA, Möllmann U, Claypool WD, Schroeder VA, Wolter WR, Suckow M, Yu H, Li S, Huang W, Zajicek J, Miller MJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28287735"}, {"Title": "Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors", "Pubmed ID": "33032189", "Reference": "Bioorg Med Chem. 2020;28:115776", "Author": "Ushiyama F, Amada H, Mihara Y, Takeuchi T, Tanaka-Yamamoto N, Mima M, Kamitani M, Wada R, Tamura Y, Endo M, Masuko A, Takata I, Hitaka K, Sugiyama H, Ohtake N", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33032189"}, {"Title": "Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action.", "Pubmed ID": "26967152", "Reference": "J Med Chem. 2016;59:3569-3574", "Author": "Kleijn LH, Oppedijk SF, 't Hart P, van Harten RM, Martin-Visscher LA, Kemmink J, Breukink E, Martin NI", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26967152"}, {"Title": "Solid-phase total synthesis of daptomycin and analogs.", "Pubmed ID": "25634084", "Reference": "Org Lett. 2015;17:748-751", "Author": "Lohani CR, Taylor R, Palmer M, Taylor SD", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25634084"}, {"Title": "Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.", "Pubmed ID": "25993059", "Reference": "J Med Chem. 2015;58:5137-5142", "Author": "Yin N, Li J, He Y, Herradura P, Pearson A, Mesleh MF, Mascio CT, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25993059"}, {"Title": "DJK-5, an anti-biofilm peptide, increases Staphylococcus aureus sensitivity to colistin killing in co-biofilms with Pseudomonas aeruginosa", "Pubmed ID": "39779734", "Reference": "NPJ Biofilms Microbiomes. 2025;11:8", "Author": "Wardell SJT, Yung DBY, Gupta A, Bostina M, Overhage J, Hancock REW, Pletzer D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39779734"}], "SPADE ID": "SPADE_N_15183", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05600", "Similarity": 1.0, "Sequence": "WNDTGKDADGSEY"}, {"SPADE_ID": "SPADE_UN_25580", "Similarity": 1.0, "Sequence": "WNDTGDADGSEW"}, {"SPADE_ID": "SPADE_UN_25582", "Similarity": 1.0, "Sequence": "WNDTGDADGSEY"}], "Hemolytic Activity": "", "Target Organism": "Acinetobacter baumannii ATCC 17978(MIC=>100µg/ml),Candida albicans ATCC 1884(MIC=>100µg/ml),Bacillus subtilis 168(MIC=0.2-0.4µg/ml),Cryptococcus neoformans ATCC 32045(MIC=>100µg/ml),Enterococcus faecium Com15(MIC=0.4-2.0µg/ml),Enterococcus faecium(MIC=0.4-2.0µg/ml),Escherichia coli DH5alpha(MIC=>100µg/ml),Escherichia coli BAS 849(MIC=50-100µg/ml),Klebsiella pneumoniae ATCC 10031(MIC=>100µg/ml),Pseudomonas aeruginosa PAO1(MIC=>100µg/ml),Salmonella enterica serovar Typhimurium IR715(MIC=>100µg/ml),Staphylococcus aureus USA 300(MIC=0.2-0.8µg/ml),Staphylococcus aureus COL(MIC=0.2-0.8µg/ml),Staphylococcus aureus NRS 100(MIC=0.2-0.8µg/ml),Staphylococcus aureus NRS 108(MIC=0.2-0.8µg/ml),Streptococcus pneumoniae TCH8431(MIC=0.1-0.2µg/ml),Acinetobacter baumannii ATCC 17961(MIC=>100µM),Burkholderia multivorans AU0100(MIC=>100µM),Staphylococcus aureus SG511(MIC=0.05µM),Staphylococcus aureus ATCC 11632(MIC=0.4µM),Acinetobacter baumannii ATCC BAA-1710(MIC=>100µM),Staphylococcus aureus(MIC=0.5-1.0µg/ml),Enterococcus faecium(MIC=0.12-4.0µg/ml),Enterococcus faecalis(MIC=0.12-4.0µg/ml),Staphylococcus aureus ATCC 29213(MIC=>256µg/ml),Staphylococcus aureus ATCC 29213(MIC=0.5µg/ml),Staphylococcus aureus ATCC 29213(MIC=0.25µg/ml),Staphylococcus aureus ATCC 29213(MIC=0.125µg/ml),Staphylococcus simulans 22(MIC=32-64µg/ml),Staphylococcus simulans 22(MIC=0.063µg/ml),Staphylococcus simulans 22(MIC=0.031µg/ml),Staphylococcus simulans 22(MIC=0.016-0.031µg/ml),Bacillus subtilis 1046(MIC=0.75µg/ml),Bacillus subtilis 1046(MIC=0.5µg/ml),Bacillus subtilis PY79(MIC=0.75µg/ml),Clostridioides difficile(MIC90=2µg/ml),Staphylococcus aureus ATCC 29213(MIC=0.5µg/ml),Enterococcus faecium ATCC 6569(MIC=>32µg/ml),Enterococcus faecalis ATCC 49452(MIC=>32µg/ml),Staphylococcus aureus(MIC=0.5-16µg/ml),Pseudomonas aeruginosa LESB58(MIC=>100µg/ml),Staphylococcus aureus USA 300 LAC(MIC=0.5µg/ml),Staphylococcus aureus USA 300 LAC(MIC=1µg/ml)"}}}